FibroGen

A biopharmaceutical company focused on developing treatments for anemia, idiopathic pulmonary fibrosis, pancreatic cancer, Duchenne muscular dystrophy and corneal blindness

Overview Structured Data Issues Contributors

Is a

Company attributes

Industry

Biomedical engineering

Synthetic chemistry

Location

0

B2X

0

CEO

Enrique Conterno

0

AngelList URL

angel.co/fibrogen

Pitchbook URL

pitchbook.com/profiles.../54928-00

Legal Name

FibroGen, Inc.

Number of Employees (Ranges)

501 – 1,000

Phone Number

+141597812000

Full Address

409 Illinois Street San Francisco, CA 94158 USA, USA0

CIK Number

Place of Incorporation

0

Investors

Ridgeback Capital

Brookside Capital

DUNS Number

8355732390

Fax Number

+1 415.978.19020

Total Funding Amount (USD)

6,023,000

Latest Funding Round Date

July 27, 2012

Stock Symbol

FGEN0

Exchange

0

Glassdoor ID

Board of Directors

0

0

Enrique Conterno

0

Benjamin Cravatt

0

Jeffrey Henderson

0

0

James A. Schoeneck

0

0

CFO

0

NAICS Code

325,4120

CAGE Code

47GX70

Wellfound ID

Country

0

Other attributes

Company Operating Status

Active

Contact Page URL

fibrogen.com/contact-us

SIC Code

2,8340

Ticker Symbol

FGEN

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like FibroGen

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.